282 related articles for article (PubMed ID: 10048980)
1. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.
Tonn JC; Kerkau S; Hanke A; Bouterfa H; Mueller JG; Wagner S; Vince GH; Roosen K
Int J Cancer; 1999 Mar; 80(5):764-72. PubMed ID: 10048980
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
3. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
5. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.
Uhm JH; Dooley NP; Villemure JG; Yong VW
Clin Exp Metastasis; 1996 Oct; 14(5):421-33. PubMed ID: 8871536
[TBL] [Abstract][Full Text] [Related]
6. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
7. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
9. BCL-2 promotes migration and invasiveness of human glioma cells.
Wick W; Wagner S; Kerkau S; Dichgans J; Tonn JC; Weller M
FEBS Lett; 1998 Dec; 440(3):419-24. PubMed ID: 9872414
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.
Wagner S; Stegen C; Bouterfa H; Huettner C; Kerkau S; Roggendorf W; Roosen K; Tonn JC
J Neurooncol; 1998 Nov; 40(2):113-22. PubMed ID: 9892093
[TBL] [Abstract][Full Text] [Related]
12. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.
Kossakowska AE; Edwards DR; Prusinkiewicz C; Zhang MC; Guo D; Urbanski SJ; Grogan T; Marquez LA; Janowska-Wieczorek A
Blood; 1999 Sep; 94(6):2080-9. PubMed ID: 10477738
[TBL] [Abstract][Full Text] [Related]
14. Overview of matrix metalloproteinase expression in cultured human cells.
Giambernardi TA; Grant GM; Taylor GP; Hay RJ; Maher VM; McCormick JJ; Klebe RJ
Matrix Biol; 1998 Mar; 16(8):483-96. PubMed ID: 9550265
[TBL] [Abstract][Full Text] [Related]
15. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
[TBL] [Abstract][Full Text] [Related]
16. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
[TBL] [Abstract][Full Text] [Related]
17. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T
Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D
Int J Cancer; 1999 May; 81(5):761-6. PubMed ID: 10328230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
